Early Detection
Symptom literacy, care pathways, and partnerships with clinics that meet women where they are.
- Symptom-recognition workshops
- Provider referral network
- Community awareness events
HopeCare Global advances early detection, education, and equitable access to care — confronting ovarian cancer in communities the world has overlooked.

Roughly 1 in 78 women will be diagnosed. We refuse to let her face those odds alone.
HopeCare Global Inc was created to advance early detection, education, and access to care for underserved communities — with a focus on ovarian cancer awareness.
Our work is grounded in clinical expertise, advocacy, and a deep commitment to reducing disparities in diagnosis and treatment. We're actively building partnerships and initiatives to drive meaningful impact — across borders, across communities, across generations.
Ovarian cancer is called “the silent killer” for a reason — and the silence has been loudest in the communities that have always been hardest to reach.
Sources: American Cancer Society · NIH · WHO IARC GLOBOCAN.
Every program is built on clinical expertise and listening — designed to move the needle on outcomes for women too often missed by the system.
Symptom literacy, care pathways, and partnerships with clinics that meet women where they are.
Clear, dignified, culturally-grounded education that breaks the stigma and starts the conversation.
Navigation, support, and resource connection for women facing diagnosis without a roadmap.
Cross-border initiatives that bring detection and care to communities historically left out of the conversation.
Because there is no standard screening test for ovarian cancer, early detection relies entirely on symptom awareness. What matters most is identifying symptoms that are new, persistent, and last more than a few weeks.
For education only, and not a substitute for professional medical advice. If something feels off and stays off, talk with your doctor.
A Pap smear detects ovarian cancer.
A Pap smear is designed to screen for cervical cancer, not ovarian cancer. Currently, there is no routine screening test for ovarian cancer in people at average risk; therefore, early detection relies entirely on symptom awareness. Seeking prompt clinical evaluation when symptoms become new, frequent, and persistent is the most effective tool we have for early intervention.
Know the signs
DNP, APRN, AGCNS-BC, CIC
“Every woman deserves to be seen, supported, and empowered to advocate for her health — regardless of zip code, color, or country.”
Dr. Harrison is a board-certified Adult-Gerontology Clinical Nurse Specialist whose career has been spent at the intersection of acute clinical care, infection prevention, and community advocacy.
She founded HopeCare Global Inc. to transform decades of clinical experience and her personal journey into action against ovarian cancer, a disease that too often hides in plain sight, particularly in Black, immigrant, and underserved communities.
Three doors into the work. Walk through whichever one fits — or open all three. The fight against ovarian cancer needs every hand we've got.
Fuel education programs, patient navigation, and community outreach. Every dollar widens our reach.
Make a GiftLend your clinical expertise, communications skills, or community connections to the movement.
Join the TeamShare resources, host a conversation, or wear teal in September — small actions, big ripples.
Share Our MissionHospitals, faith communities, schools, sororities, corporate wellness — if you have a room of women, we have a program.